Background: HELLP syndome is a life-threatening condition complicating 0,5-0,9% of all pregnancies. It is characterized by endothelial dysfunction associated with microangiopathy. The syndrome is named after the triad of diagnostic criteria: Hemolysis, Elevated Liver enzyme levels, and Low Platelet levels, and it is mostly classified using The Mississippi-Triple Class System. The basic treatment usually involves early delivery, antihypertensive drugs, high-dose magnesium sulphate, corticosteroids and close monitoring of fluid balance and coagulation parameters. About 30% of the cases develop

Simple item page
dc.contributor.authorBydžovská Ivanacs
dc.contributor.authorZemanová Dagmarcs
dc.contributor.authorGavendová Hanacs
dc.contributor.authorŠimetka O.cs
dc.date.accessioned2020-06-08T09:42:23Z
dc.date.available25-02-2019en
dc.date.available2020-06-08T09:42:23Z
dc.date.issued2018cs
dc.date.updated29-04-2019en
dc.format.extent0cs
dc.identifier.urihttps://dspace.tul.cz/handle/15240/155885
dc.language.isoengcs
dc.relation.ispartofseries0cs
dc.subjectHELLP syndomecs
dc.titleBackground: HELLP syndome is a life-threatening condition complicating 0,5-0,9% of all pregnancies. It is characterized by endothelial dysfunction associated with microangiopathy. The syndrome is named after the triad of diagnostic criteria: Hemolysis, Elevated Liver enzyme levels, and Low Platelet levels, and it is mostly classified using The Mississippi-Triple Class System. The basic treatment usually involves early delivery, antihypertensive drugs, high-dose magnesium sulphate, corticosteroids and close monitoring of fluid balance and coagulation parameters. About 30% of the cases developcs
local.identifier.publikace6514
Files
Collections